Insights into the Uptake Mechanism of NrTP, A Cell-Penetrating Peptide Preferentially Targeting the Nucleolus of Tumour Cells

Chemical Biology and Drug Design

Volumn 79, Issue 6, 2012, Pages 907-915

  Rádis Baptista, Gandhi ^a,b   de la Torre, Beatriz G ^a   Andreu, David ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Cell penetrating peptide; Clathrin mediated endocytosis; Nucleolar localization sequence; Theranostic peptide; Tumour cell target

Indexed keywords

CELL PENETRATING PEPTIDE; CLATHRIN; NRTP1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL COMPARTMENTALIZATION; CELL CYCLE ARREST; CELL HOMING; CONFOCAL LASER MICROSCOPY; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NUCLEOLAR LOCALIZATION SIGNAL; NUCLEOLUS; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN TARGETING; PROTEIN TRANSPORT; UTERINE CERVIX CARCINOMA;

AMINO ACID SEQUENCE; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL NUCLEOLUS; CELL-PENETRATING PEPTIDES; CLATHRIN; ENDOCYTOSIS; HELA CELLS; HUMANS;

EID: 84860467135     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2012.01377.x     Document Type: Article

References (57)

1. Blobel G. (2000) Protein targeting (Nobel lecture). ChemBioChem;1:86-102.
2. Davis J.R., Kakar M., Lim C.S. (2007) Controlling protein compartmentalization to overcome disease. Pharm Res;24:17-27.
3. Pouton C.W., Wagstaff K.M., Roth D.M., Moseley G.W., Jans D.A. (2007) Targeted delivery to the nucleus. Adv Drug Deliv Rev;59:698-717.
4. Tkach J.M., Glover J.R. (2008) Nucleocytoplasmic trafficking of the molecular chaperone Hsp104 in unstressed and heat-shocked cells. Traffic;9:39-56.
5. Wu W.W., Pante N. (2009) The directionality of the nuclear transport of the influenza A genome is driven by selective exposure of nuclear localization sequences on nucleoprotein. Virol J;6:68.
6. Derossi D., Joliot A.H., Chassaing G., Prochiantz A. (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem;269:10444-10450.
7. Vives E., Brodin P., Lebleu B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem;272:16010-16017.
8. Elliott G., O'Hare P. (1997) Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell;88:223-233.
9. Pooga M., Hallbrink M., Zorko M., Langel U. (1998) Cell penetration by transportan. FASEB J;12:67-77.
10. Goun E.A., Pillow T.H., Jones L.R., Rothbard J.B., Wender P.A. (2006) Molecular transporters: synthesis of oligoguanidinium transporters and their application to drug delivery and real-time imaging. ChemBioChem;7:1497-1515.
11. Zorko M., Langel U. (2005) Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev;57:529-545.
12. Heitz F., Morris M.C., Divita G. (2009) Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol;157:195-206.
13. Morris M.C., Deshayes S., Heitz F., Divita G. (2008) Cell-penetrating peptides: from molecular mechanisms to therapeutics. Biol Cell;100:201-217.
14. Kersemans V., Kersemans K., Cornelissen B. (2008) Cell penetrating peptides for in vivo molecular imaging applications. Curr Pharm Des;14:2415-2447.
15. Martin M., Rice K. (2007) Peptide-guided gene delivery. AAPS J;9:E18-E29.
16. El-Andaloussi S., Johansson H.J., Holm T., Langel U. (2007) A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids. Mol Ther;15:1820-1826.
17. Segura J., Fillat C., Andreu D., Llop J., Millan O., de la Torre B.G., Nikolovski Z., Gomez V., Andreu N., Pinyot A., Castelo R., Gispert J.D., Pascual J.A. (2007) Monitoring gene therapy by external imaging of mRNA: pilot study on murine erythropoietin. Ther Drug Monit;29:612-618.
18. Zhou M., Ghosh I. (2007) Quantum dots and peptides: a bright future together. Biopolymers;88:325-339.
19. Stewart K.M., Horton K.L., Kelley S.O. (2008) Cell-penetrating peptides as delivery vehicles for biology and medicine. Org Biomol Chem;6:2242-2255.
20. Deshayes S., Morris M., Heitz F., Divita G. (2008) Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv Drug Deliv Rev;60:537-547.
21. Doherty G.J., McMahon H.T. (2009) Mechanisms of endocytosis. Annu Rev Biochem;78:857-902.
22. Gump J.M., Dowdy S.F. (2007) TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol Med;13:443-448.
23. Vendeville A., Rayne F., Bonhoure A., Bettache N., Montcourrier P., Beaumelle B. (2004) HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol Biol Cell;15:2347-2360.
24. Wadia J.S., Stan R.V., Dowdy S.F. (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med;10:310-315.
25. Jones S.W., Christison R., Bundell K., Voyce C.J., Brockbank S.M., Newham P., Lindsay M.A. (2005) Characterisation of cell-penetrating peptide-mediated peptide delivery. Br J Pharmacol;145:1093-1102.
26. Fischer R., Kohler K., Fotin-Mleczek M., Brock R. (2004) A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J Biol Chem;279:12625-12635.
27. Hodgson W.C., Isbister G.K. (2009) The application of toxins and venoms to cardiovascular drug discovery. Curr Opin Pharmacol;9:173-176.
28. Kerkis A., Kerkis I., Radis-Baptista G., Oliveira E.B., Vianna-Morgante A.M., Pereira L.V., Yamane T. (2004) Crotamine is a novel cell-penetrating protein from the venom of rattlesnake Crotalus durissus terrificus. FASEB J;18:1407-1409.
29. Nascimento F.D., Hayashi M.A., Kerkis A., Oliveira V., Oliveira E.B., Radis-Baptista G., Nader H.B., Yamane T., Tersariol I.L., Kerkis I. (2007) Crotamine mediates gene delivery into cells through the binding to heparan sulfate proteoglycans. J Biol Chem;282:21349-21360.
30. Fadel V., Bettendorff P., Herrmann T., de Azevedo W.F. Jr, Oliveira E.B., Yamane T., Wuthrich K. (2005) Automated NMR structure determination and disulfide bond identification of the myotoxin crotamine from Crotalus durissus terrificus. Toxicon;46:759-767.
31. Vila-Perelló M., Tognon S., Sánchez-Vallet A., García-Olmedo F., Molina A., Andreu D. (2006) A minimalist design approach to antimicrobial agents based on a thionin template. J Med Chem;49:448-451.
32. Radis-Baptista G., de la Torre B.G., Andreu D. (2008) A novel cell-penetrating peptide sequence derived by structural minimization of a snake toxin exhibits preferential nucleolar localization. J Med Chem;51:7041-7044.
33. Shaw P., Doonan J. (2005) The nucleolus. Playing by different rules? Cell Cycle;4:102-105.
34. Emmott E., Hiscox J.A. (2009) Nucleolar targeting: the hub of the matter. EMBO Rep;10:231-238.
35. Harper J.V. (2005) Synchronization of cell populations in G1/S and G2/M phases of the cell cycle. Methods Mol Biol;296:157-166.
36. Su G., Meyer K., Nandini C.D., Qiao D., Salamat S., Friedl A. (2006) Glypican-1 Is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells. Am J Pathol;168:2014-2026.
37. Meyers S., Hiebert S.W. (2000) Alterations in subnuclear trafficking of nuclear regulatory factors in acute leukemia. J Cell Biochem Suppl;35:93-98.
38. Breton M., Berrou E., Brahimi-Horn M.C., Deudon E., Picard J. (1986) Synthesis of sulfated proteoglycans throughout the cell cycle in smooth muscle cells from pig aorta. Exp Cell Res;166:416-426.
39. Skandalis S.S., Stylianou M., Vynios D.H., Papageorgakopoulou N., Theocharis D.A. (2007) The structural and compositional changes of glycosaminoglycans are closely associated with tissue type in human laryngeal cancer. Biochimie;89:1573-1580.
40. Kosuge M., Takeuchi T., Nakase I., Jones A.T., Futaki S. (2008) Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. Bioconjug Chem;19:656-664.
41. Mueller J., Kretzschmar I., Volkmer R., Boisguerin P. (2008) Comparison of cellular uptake using 22 CPPs in 4 different cell lines. Bioconjug Chem;19:2363-2374.
42. Cawood R., Harrison S.M., Dove B.K., Reed M.L., Hiscox J.A. (2007) Cell cycle dependent nucleolar localization of the coronavirus nucleocapsid protein. Cell Cycle;6:863-867.
43. Reed M.L., Dove B.K., Jackson R.M., Collins R., Brooks G., Hiscox J.A. (2006) Delineation and modelling of a nucleolar retention signal in the coronavirus nucleocapsid protein. Traffic;7:833-848.
44. Lusk C.P., Blobel G., King M.C. (2007) Highway to the inner nuclear membrane: rules for the road. Nat Rev Mol Cell Biol;8:414-420.
45. Conner S.D., Schmid S.L. (2003) Regulated portals of entry into the cell. Nature;422:37-44.
46. Wadia J.S., Dowdy S.F. (2002) Protein transduction technology. Curr Opin Biotechnol;13:52-56.
47. Illinger D., Poindron P., Kuhry J.G. (1991) Fluid phase endocytosis investigated by fluorescence with trimethylamino-diphenylhexatriene in L929 cells, the influence of temperature and of cytoskeleton depolymerizing drugs. Biol Cell;73:131-138.
48. Hällbrink M., Oehlke J., Papsdorf G., Bienert M. (2004) Uptake of cell-penetrating peptides is dependent on peptide-to-cell ratio rather than on peptide concentration. Biochim Biophys Acta;1667:222-228.
49. Rodrigues M., de la Torre B.G., Rádis-Baptista G., Santos N.C., Andreu D. (2011) Efficient cellular delivery of β-galactosidase mediated by NrTPs, a new family of cell-penetrating peptides. Bioconjug Chem;22:2339-2344.
50. Poon G.M., Gariépy J. (2007) Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells. Biochem Soc Trans;35(Pt 4):788-793.
51. Tyagi M., Rusnati M., Presta M., Giacca M. (2001) Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans. J Biol Chem;276:3254-3261.
52. Silhol M., Tyagi M., Giacca M., Lebleu B., Vives E. (2002) Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur J Biochem;269:494-501.
53. West M.A., Bretscher M.S., Watts C. (1989) Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J Cell Biol;109:2731-2739.
54. Yumoto R., Nishikawa H., Okamoto M., Katayama H., Nagai J., Takano M. (2006) Clathrin-mediated endocytosis of FITC-albumin in alveolar type II epithelial cell line RLE-6TN. Am J Physiol;290:L946-L955.
55. Wang L.H., Rothberg K.G., Anderson R.G. (1993) Misassembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol;123:1107-1117.
56. Zullo A.J., Michaud M., Zhang W., Grusby M.J. (2009) Identification of the small protein rich in arginine and glycine (SRAG). J Biol Chem;284:12504-12511.
57. Strebhardt K., Ullrich A. (2008) Paul Ehrlich's magic bullet concept: 100years of progress. Nat Rev Cancer;8:473-480.